亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Extra-pleural pneumonectomy in the setting of tri-modality therapy for patients with malignant pleural mesothelioma

        2013-06-12 12:33:49AlexanderChiSijinWenNamNguyenGeraldineJacobsonScotRemickWilliamTseZhongxingLiao
        Chinese Journal of Cancer Research 2013年2期

        Alexander Chi, Sijin Wen, Nam P. Nguyen, Geraldine Jacobson, Scot Remick, William Tse, Zhongxing Liao

        1Department of Radiation Oncology, West Virginia University, Morgantown, WV 26506, USA;2Department of Biostatistics, West Virginia University, Morgantown, WV 26506, USA;3Department of Radiation Oncology, University of Arizona, Tucson, AZ 85724, USA;4Mary Babb Randolph Cancer Center, Morgantown, WV 26506, USA;5Department of Hematology Oncology, West Virginia University, Morgantown, WV 26506, USA;6Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

        Extra-pleural pneumonectomy in the setting of tri-modality therapy for patients with malignant pleural mesothelioma

        Alexander Chi1, Sijin Wen2, Nam P. Nguyen3, Geraldine Jacobson1, Scot Remick4, William Tse5, Zhongxing Liao6

        1Department of Radiation Oncology, West Virginia University, Morgantown, WV 26506, USA;2Department of Biostatistics, West Virginia University, Morgantown, WV 26506, USA;3Department of Radiation Oncology, University of Arizona, Tucson, AZ 85724, USA;4Mary Babb Randolph Cancer Center, Morgantown, WV 26506, USA;5Department of Hematology Oncology, West Virginia University, Morgantown, WV 26506, USA;6Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

        Corresponding to:Alexander Chi, M.D. Department of Radiation Oncology, West Virginia University 1 Medical Center Dr. Morgantown, WV 26505, USA. Email: achiaz2010@gmail.com.

        Submitted Jan 16, 2013. Accepted for publication Feb 19, 2013.

        Scan to your mobile device or view this article at:http://www.thecjcr.org/article/view/1507/2470

        Although declining in the US due to restrictions of asbestos exposure, malignant pleural mesothelioma (MPP) remains a very serious thoracic malignancy that is rising in incidence worldwide (1). Trimodality therapy with chemotherapy and radiotherapy combined with extrapleural pneumonectomy (EPP) has gained acceptance given the acceptable mortality rate (<5%) and long term survival reported in patients with epithelial histology, negative margins, and no extrapleural lymph node involvement after trimodality treatment (2). Since then, multiple studies have been published reported excellent median survival of >20 months after trimodality therapy (1). However, this treatment approach continues to be controversial given recent publications demonstrating that EPP may lead to poorer survival and increased mortality from surgery when compared with pleurectomy/ decortication (P/D) (3-5). As shown in a large retrospective review of patients who have undergone EPP or P/D, the operative mortality was found to be 7% after EPP and 4% after P/D with a hazard rate of 1.4 for EPP found after multivariate analysis (P<0.001) (3). In a non-randomized prospective study comparing EPP and P/D in the setting of trimodality therapy, prolonged median survival was observed after P/D, hyperthermic pleural lavage with povidone-iodine, and adjuvant chemotherapy and prophylactic radiotherapy when compared with neoadjuvant chemotherapy, EPP, and adjuvant radiotherapy (23vs. 12.8 months, P=0.004). Although improved survival is suggested, no conclusion regarding to whether EPP will lead to inferior survival when compared with P/D can be made due to the nature of these studies. In 2011, a prospective study (MARS) that attempts to compare EPP and P/D in a randomized fashion was reported (5). The aim of this study was to investigate the effect of EPP in the context of trimodality therapyvs. no EPP on the survival and quality of life in patients with malignant pleural mesothelioma. Due to the rarity of this disease, the feasibility of randomizing 50 patients in 1 year after neoadjuvant chemotherapy was explored. Among 112 patients registered between 2005 and 2008, 50 patients (T1-T3, N0-N1, and M0) were randomized to EPPvs. no EPP (24vs. 26). Among the 24 patients randomized to EPP, the procedure was only completed in 16 patients (3 total operative mortalities) and 8 of these 16 patients received radical radiotherapy afterwards. While no significant differences between groups were reported in the quality of life analyses, the hazard ratio for overall survival between the EPP and no EPP groups were 2.75 (P=0.016) after adjusting for sex, histological subtype, stage, and age at randomization. Although the data analysis was appropriate, the sample size is too small to make any conclusion regarding to patient survival after EPPvs. no EPP (power calculation was based on 670 patients). Also, the final conclusion of EPP shortens survival is not supported by statistical inference, but just based on the descriptive statistics. For example, a formal boundary (a cutoff of a statistic) in the interim analysis should be used to make a statistical inference or conclusion. Therefore, theconclusion of this study really needs to be interpreted with caution.

        More recently, a systematic review of trimodality therapy for malignant pleural mesothelioma has been conducted (6). Among the 16 studies included, the median survival ranged from 12.8 to 46.9 months and the perioperative mortality varied from 0 to 12.5% but mostly <5%. Large variation in median survival has been observed, but 6 studies reported median survival of ≥20 months. Given the current level of evidence, further studies need to be conducted to further investigate the effect of EPP on the survival of patients with malignant pleural mesothelioma, especially when advanced technology is applied in the delivery of adjuvant RT, which may potentially improve the survival of patients with malignant pleural mesothelioma in the setting of both EPP and P/D (7,8).

        Acknowledgements

        Disclosure:The authors declare no conflict of interest.

        1. Chi A, Liao Z, Nguyen NP, et al. Intensity-modulated radiotherapy after extrapleural pneumonectomy in the combined-modality treatment of malignant pleural mesothelioma. J Thorac Oncol 2011;6:1132-41.

        2. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-63; discussion 63-5.

        3. Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008;135:620-6, 626.e1-3.

        4. Lang-Lazdunski L, Bille A, Lal R, et al. Pleurectomy/ decortication in superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol 2012;7:737-43.

        5. Treasure T, Lang-Lazdunski L, Waller D, et al. Extrapleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011;12:763-72.

        6. Cao C, Tian D, Manganas C, et al. Systematic review of trimodality therapy for patients with malignant pleural mesothelioma. Ann Cardiothorac Surg 2012;1:428-37.

        7. Tonoli S, Vitali P, Scotti V, et al. Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series. Radiother Oncol 2011;101:311-5.

        8. Minatel E, Trovo M, Polesel J, et al. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung. J Thorac Oncol 2012;7:1862-6.

        Cite this article as:Chi A, Wen S, Nguyen NP, Jacobson G, Remick S, Tse W, Liao Z. Extra-pleural pneumonectomy in the setting of tri-modality therapy for patients with malignant pleural mesothelioma. Chin J Cancer Res 2013;25(2):128-129. doi: 10.3978/j.issn.1000-9604.2013.02.05

        10.3978/j.issn.1000-9604.2013.02.05

        成人全部免费的a毛片在线看| 国产一区日韩二区欧美三区| 亚洲电影中文字幕| av网站在线观看二区| 开心五月天第四色婷婷| 无码少妇精品一区二区免费动态| 欧美日韩亚洲成人| 亚洲国产av自拍精选| 国产精品三区四区亚洲av| 曰韩亚洲av人人夜夜澡人人爽| 精品久久久久久久久免费午夜福利| 国产熟女自拍视频网站| 三上悠亚亚洲精品一区| 人妻色综合网站| 最新国产一区二区精品久久| 亚洲天堂免费一二三四区| 男女主共患难日久生情的古言| 亚洲av日韩av在线观看| 欧美一欧美一区二三区性| 国产人妖一区二区av| 久久久精品人妻一区二区三区四区| 人妻少妇精品视频一区二区三区 | 中文无码熟妇人妻av在线| 亚洲欧美日韩在线观看一区二区三区| 99久久久精品国产性黑人| 久久精品不卡一区二区三区| 日日碰狠狠添天天爽| 一本到无码AV专区无码| 亚洲一区二区三区av天堂| 国产成人亚洲精品无码青| 精品成人乱色一区二区| 福利片免费 亚洲| 日韩中文字幕一区二区二区| 久久久www成人免费精品| 一本到无码AV专区无码| 中文字幕精品一区二区三区av| 熟妇人妻无乱码中文字幕真矢织江| 亚洲国产综合精品 在线 一区 | 日韩精品综合一本久道在线视频| 国产熟妇高潮呻吟喷水| 亚洲高清国产品国语在线观看|